Prognostic Significance of the Coagulation and Complement Systems in Critical COVID-19 Infection.

Area of Science:

• Immunology
• Pathophysiology
• Pharmacology

Background:

• COVID-19 presents diverse clinical outcomes, from asymptomatic to fatal.
• Severe disease involves immune dysregulation, cytokine storms, and links to obesity and type-2 diabetes.
• Neutrophils, complement system hyperactivity, and coagulopathy are implicated in severe COVID-19 pathogenesis.

Purpose of the Study:

• To explore the complex interplay of immune responses, metabolic factors, complement activation, and coagulation in severe COVID-19.
• To review the therapeutic strategies targeting these pathways, including anticoagulation and complement inhibition.

Main Methods:

• Review of existing literature on COVID-19 pathophysiology.
• Analysis of clinical observations regarding immune cell involvement and mediator production.
• Examination of the cross-talk between complement and coagulation systems in critical illness.

Main Results:

• Severe COVID-19 is characterized by a cytokine storm, potentially exacerbated by metabolic conditions.
• Pathological hyperactivity of the complement system and coagulopathy are observed in critically ill patients.
• An intricate cross-talk exists between complement and coagulation systems, contributing to disease severity.

Conclusions:

• Understanding the interconnectedness of immune, complement, and coagulation systems is crucial for managing severe COVID-19.
• Anticoagulants (e.g., enoxaparin, apixaban) and complement inhibitors (e.g., eculizumab) show potential therapeutic benefits.
• Further research and clinical experience are vital for optimizing treatment strategies against severe COVID-19 and similar future conditions.